Scpharmaceuticals Inc (SCPH) — Cash Flow-to-Debt Ratio
Scpharmaceuticals Inc (SCPH) has a Cash Flow-to-Debt Ratio of -0.16x as of June 2025, meaning its operating cash flow of $-16.11 Million could theoretically repay 0% of its total liabilities ($101.57 Million) in one year. Explore SCPH cash generation efficiency to assess how effectively this company generates cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Scpharmaceuticals Inc Cash Flow-to-Debt Ratio (2015–2024)
Historical debt coverage capacity for Scpharmaceuticals Inc across 10 annual periods. Also explore Scpharmaceuticals Inc (SCPH) total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Scpharmaceuticals Inc (2015–2024)
Year-by-year debt coverage analysis for Scpharmaceuticals Inc. For market capitalisation and broader financial context, see Scpharmaceuticals Inc (SCPH) total market value.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.75x | $-70.54 Million | $94.20 Million | ▲ +27.6% |
| 2023 | -1.03x | $-59.24 Million | $57.26 Million | ▼ -54.9% |
| 2022 | -0.67x | $-34.58 Million | $51.76 Million | ▲ +44.5% |
| 2021 | -1.20x | $-27.15 Million | $22.57 Million | ▼ -16.8% |
| 2020 | -1.03x | $-27.69 Million | $26.88 Million | ▲ +12.3% |
| 2019 | -1.17x | $-30.44 Million | $25.92 Million | ▲ +38.8% |
| 2018 | -1.92x | $-28.81 Million | $15.01 Million | ▼ -35.8% |
| 2017 | -1.41x | $-22.68 Million | $16.05 Million | ▼ -602.6% |
| 2016 | -0.20x | $-15.46 Million | $76.85 Million | ▲ +58.1% |
| 2015 | -0.48x | $-9.64 Million | $20.09 Million | — |